Search Within

Jessica Flynn

  1. "Daniel Gomez"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
Groups
  1. Biostatistics Service (10)
  2. Department of Medicine (10)
  3. Epidemiology and Biostatistics (10)
  4. Radiation Oncology, Department of (10)
  5. Solid Tumor Oncology Division (10)
  6. Thoracic Oncology (10)

More Groups

People
  1. Daniel Gomez (10)
  2. Andreas Rimner (9)
  3. Zhigang Zhang (9)
  4. Alexander Drilon (5)
  5. Emily Lebow (5)
  6. Charles Rudin (4)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (5)
  4. 2020 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. JCO Precision Oncology (1)
  3. Journal of Thoracic Oncology (1)
  4. Lancet (1)
  5. Lung Cancer (1)
  6. Neuro-Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (5)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Ireland Ltd. (1)
  4. Elsevier Science, Inc. (1)
  5. Oxford University Press (1)
  6. Translational Lung Cancer Research (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stereotactic body radiation therapy for stage IIA to IIIA inoperable non-small cell lung cancer: A phase 1 dose-escalation trial
    Journal Article

    Rimner, A.; Gelblum, D. Y.; Wu, A. J.; Shepherd, A. F.; Mueller, B.; Zhang, S.; Cuaron, J.; Shaverdian, N.; Flynn, J.; Fiasconaro, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Journal Article

    Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of central nervous system clinico-genomic outcomes in ALK-positive non-small cell lung cancer patients with brain metastases treated with alectinib
    Journal Article

    Miao, E.; Eichholz, J. E.; Lebow, E. S.; Flynn, J.; Zhang, Z.; Walch, H.; Hubbeling, H.; Beal, K.; Moss, N. S.; Yu, K. K.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer
    Journal Article

    Haseltine, J. M.; Offin, M.; Flynn, J. R.; Zhang, Z.; Lebow, E. S.; Aziz, K.; Makhnin, A.; Eichholz, J.; Lim, L. P.; Li, M.; more...
    Translational Lung Cancer Research (2022)

    Fulltext@MSK | Save
  • CNS outcomes in ALK fusion positive NSCLC patients with BM who received alectinib with or without local therapy
    Meeting Abstract

    Miao, E.; Lebow, E. S.; Eichholz, J.; Flynn, J.; Zhang, Z.; Hubbeling, H. G.; Beal, K.; Moss, N. S.; Yu, K.; Yang, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Circulating tumor DNA as a biomarker in oligometastatic non-small cell lung cancer
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y.; Razavi, P.; Reis, J. S.; Flynn, J.; Zhang, Z.; Tu, H. Y.; Bertucci, C.; Lim, L. P.; Li, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save